HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trade Groups Affirm Cosmetic Ingredient Review Support With View For Change

This article was originally published in The Rose Sheet

Executive Summary

Personal Care Products Council and Independent Cosmetic Manufacturers and Distributors assert confidence in and support for Cosmetic Ingredient Review while also signaling an openness to alterations to the expert panel’s role as Congress considers changes to its purview. PCPC characterized recent WVE report’s claims as “baseless,” highlighting the expert panelists’ “world renowned” expertise as well as the panel’s open, public forums and peer-reviewed assessments.

You may also be interested in...

CIR Defends Independence, Suggests Confusion Prompted WVE Criticism

Cosmetic Ingredient Review head Bart Heldreth suggests that not only are Women's Voices for the Earth's concerns misguided, but the group may hold a grudge from past instances when the CIR Expert Panel was in disagreement with the group. Heldreth maintains the expert panel “has established a strong record of protecting public health through its reviews and safety assessments of ingredients used in cosmetics.

Cosmetic Ingredient Review Program Will Get 'Fresh Look' In 2018 – PCPC

With federal legislation on the table to task FDA with cosmetic ingredient reviews and provide accredited third parties with the opportunity to inform the agency's assessment work, the Personal Care Products Council plans to give the industry-funded Cosmetic Ingredient Review program a "fresh look."

Senate Health Committee Releases Cosmetics Reform Discussion Draft

The committee's discussion draft of cosmetics reform legislation combines elements of the proposed Personal Care Products Safety Act and FDA Cosmetic Safety and Modernization Act, but most closely aligns with the former. NGOs likely will be pleased; small businesses, perhaps not so much

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts